News

Recent News +++

Phase I DSTP3086S Trial Results Published

Media Relations by PCCTC November 11, 2019

PCCTC study demonstrates safety and antitumor activity of humanized immunoglobulin G1 anti...

Learn More

PCCTC Investigators Drs. Rathkopf and McBride Receive Prestigious SU2C Grant

Press Releases by PCCTC October 17, 2019

Award will fund novel trial using immunotherapy combined with radiation and hormone therap...

Learn More

PCCTC Germline Genetics Working Group Publishes Results

Press Releases by PCCTC July 29, 2019

Study published in Clinical Genitourinary Cancer argues multidisciplinary efforts are key ...

Learn More

PCCTC Working Group Publishes Genetic Testing Manuscript

Press Releases by PCCTC April 26, 2019

Investigators from the Prostate Cancer Clinical Trials Consortium (PCCTC) formed the Germl...

Learn More

Phase III DORA Study Now Enrolling Patients with mCRPC

Press Releases by PCCTC April 19, 2019

The phase III DORA study (ClinicalTrials.gov Identifier: NCT03574571) led by PCCTC investi...

Learn More

Blood Test Predicts Resistance To Hormonal Therapy

Press Releases by MedPage Today March 18, 2019

AR-V7 successfully predicted resistance to hormonal therapy in advanced prostate cancer

Learn More

Clinical Implications of Genetics in Prostate Cancer

Press Releases by ASCO Daily News February 18, 2019

PCCTC investigator Dr. Heather Cheng discusses future of cancer care.

Learn More

The PCCTC Is Expanding

Press Releases by PCCTC February 15, 2019

The PCCTC is currently seeking a Quality Manager and Clinical Data Manager to join its tea...

Learn More

PCCTC Medical Director Discusses Biomarkers in Prostate Cancer

Press Releases by PCCTC December 18, 2018

Dr. Michael Morris describes the need to be stratified by risk through biomarkers.

Learn More

Movember Seeking Clinical Research Project Manager for IRONMAN Registry

Press Releases by PCCTC October 26, 2018

The PCCTC serves as the the program’s Global Clinical and Data Coordination Center. ...

Learn More

PCCTC Germline Genetics Working Group Publishes White Paper

Press Releases by PCCTC August 31, 2018

Manuscript published in the Journal of Clinical Oncology – Precision Oncology discus...

Learn More

Advocacy Symposium Led by PCCTC Investigator

Media Relations by PCCTC August 10, 2018

Dr. Elisabeth Heath of Karmanos Cancer Institute will head up the 8th Annual Prostate Canc...

Learn More

Blood Test Predicts Treatment Response, Survival in Metastatic Disease

Media Relations by PCCTC June 29, 2018

PCCTC Scientific Oversight Committee Chair, Howard I. Scher, MD leads international study....

Learn More

The PCCTC Is Expanding Its Trial Management Capabilities

Media Relations by PCCTC June 12, 2018

To better meet the needs of our partners the PCCTC is expanding its infrastructure. Our ce...

Learn More

IRONMAN: An International Registry To Improve Outcomes in Men with Advanced Prostate Cancer

Press Releases by UroToday April 18, 2018

PCCTC investigator Dr. Lorelei Mucci discusses innovative new registry initiative.

Learn More

PCCTC-Developed Apalutamide Gains FDA Approval

Press Releases by PCCTC March 9, 2018

On February 14, 2018, the Food and Drug Administration (FDA) approved the next-generation ...

Learn More

PCCTC Muscadine (MPX) Study Finds Activity in Select Genotypes

Press Releases by PCCTC December 19, 2017

A pre-planned subset analysis using a polymorphism of the superoxide dismutase-2 (SOD2) ge...

Learn More

The PCCTC Salutes Its Very Own Angie Avery

Press Releases by PCCTC November 7, 2017

Celebrating Veterans Week 2017, we salute Angie Avery, PCCTC Project Coordinator.

Learn More

Timeline of PCCTC Clinical Contributions

Press Releases by PCCTC November 6, 2017

The Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP)...

Learn More

Early Development Led by the PCCTC, FDA Approval Now Sought for Apalutamide

Media Relations by Jason Harris - OncLive October 12, 2017

A new drug application (NDA) has been submitted to the FDA for apalutamide (ARN-509) for t...

Learn More

7th Annual Prostate Cancer Advocacy Symposium: A National Summit in Detroit

Press Releases by PCCTC September 12, 2017

The 7th Annual Prostate Cancer Advocacy Symposium: A National Summit in Detroit brings tog...

Learn More

The PCCTC Selects Tempus as Sequencing and Analytics Provider for Phase II Clinical Trial

Press Releases by Tempus August 17, 2017

Tempus, a technology company focused on helping doctors personalize cancer care by collect...

Learn More

Dr. Howard I. Scher on the Definition of Castration-Sensitive/Naive Prostate Cancer

Press Releases by UroToday August 7, 2017

The PCCTC’s Scientific Oversight Committee chair speaks with UroToday at the 2017 Ad...

Learn More

PCCTC Trial Establishes Safety, Antitumor Activity of Apalutamide

Press Releases by PCCTC July 25, 2017

Study represents a new standard that demonstrates the patient experience, useful for physi...

Learn More

Dr. Lorelei Mucci Discusses Innovative IRONMAN Registry

Press Releases by PCCTC July 6, 2017

IRONMAN: An International Registry To Improve Outcomes in Men with Advanced Prostate Cance...

Learn More

Signature for Aggressive-Variant CRPC Predicts Platinum Sensitivity

Press Releases by Bryant Furlow June 8, 2017

PCCTC study serves as the foundation for a therapeutically relevant classification of pros...

Learn More

PCCTC Trial Results: Neoadjuvant Enzalutamide Prior to Prostatectomy

Press Releases by PCCTC May 9, 2017

Study led by the University of Washington published in Clinical Cancer Research provides e...

Learn More

The PCCTC Is Seeking Talented Clinical Research Professionals

Press Releases by PCCTC April 24, 2017

The PCCTC is currently seeking talented clinical research professionals to fill the positi...

Learn More

Dr. Taplin, Leader in Novel Targeted Therapy Development

Press Releases by PCCTC March 30, 2017

The Prostate Cancer Foundation (PCF) highlights the accomplishments of PCCTC investigator ...

Learn More

Drs. Mucci and Kantoff on Outcomes Research and IRONMAN

Press Releases by Alicia Morgans, UroToday March 23, 2017

Lorelei Mucci and Phil Kantoff, MD, discuss the PCCTC-managed International Registry to Im...

Learn More

PCCTC’s Vital Role in Blood Profiling Atlas in Cancer (Blood PAC)

Press Releases by PCCTC December 20, 2016

WASHINGTON, D.C. December 20, 2016 – The Breast Cancer Research Foundation (BCRF) and th...

Learn More

PCCTC Leader Discusses Future of Liquid Biopsies in Prostate Cancer

Press Releases by Gina Columbus November 22, 2016

Dr. Howard I. Scher, PCCTC Scientific Oversight Committee Chair, speaks on predicting sens...

Learn More

Team PCCTC Joins Movember Effort

Media Relations by PCCTC November 1, 2016

Prostate cancer is the second most common cancer in men worldwide. The PCCTC and Movember ...

Learn More

The PCCTC to Advance VP Biden’s Cancer Moonshot Goals

Press Releases by PCCTC October 27, 2016

PCCTC involved with new partnership in pursuit of creating an open database for liquid ...

Learn More

ESMO 2016: PCCTC Study Benefits Men With Neuroendocrine Prostate Cancer

Press Releases by Jason Hoffman, PharmD, RPh October 10, 2016

The selective aurora A kinase inhibitor Alisertib may benefit some patients with neuroend...

Learn More

PCCTC Investigator Dr. Maha Hussain Develops Prostate Cancer Advances

Press Releases by Laura Panjwani @OncEditorLaura October 4, 2016

Innovative physician-scientist exemplifies research excellence while maintaining strong co...

Learn More

FDA-Designated Breakthrough Therapy Available in PCCTC Clinical Trial

Press Releases by PCCTC August 5, 2016

The US Food and Drug Administration (FDA) recently granted Novartis’ CDK4/6 inhibitor LE...

Learn More

PCCTC Facilitates Groundbreaking Prostate Cancer Gene Sequencing Study

Press Releases by PCCTC July 7, 2016

Men with metastatic disease found more likely to harbor mutations in genes mediating DNA-r...

Learn More

CDMRP Releases FY16 Clinical Consortium Research Site Award

Press Releases by PCCTC June 28, 2016

The US Department of Defense (DoD) Prostate Cancer Research Program (PCRP), a division of...

Learn More

PCCTC Collaborates with Florence Healthcare to Enhance Regulatory Document Management Capabilities

Press Releases by PCCTC June 10, 2016

ATLANTA, GA and NEW YORK, June 10, 2016 – Florence Healthcare, developer of the innovati...

Learn More

PCCTC Investigators Establish Guidelines for CRPC Clinical Trials

Press Releases by PCCTC May 31, 2016

The latest recommendations from Prostate Cancer Working Group 3 (PCWG3) have already been...

Learn More

VT-464, Drug in Development with PCCTC, Fast Tracked by FDA

Press Releases by WRAL TechWire January 8, 2016

Innocrin’s CYP17 lyase inhibitor seviteronel (VT-464), currently in PCCTC-led early ...

Learn More

The PCCTC: Enabling the Practice of Precision Medicine

Press Releases by CDMRP November 24, 2015

The Congressionally Directed Medical Research Programs (CDMRP) selects the PCCTC’s c...

Learn More

The PCCTC and Movember: Supporting Prostate Cancer Research and Awareness.

Press Releases by PCCTC November 12, 2015

Over 500 investigators, and research staff from PCCTC clinical research sites have come to...

Learn More

Landmark Trial the First to Show the Benefit of Precision Medicine in Prostate Cancer

Press Releases by The Prostate Cancer Foundation October 30, 2015

Oct. 28, 2015 — A major new trial, funded in part by the Prostate Cancer Foundation ...

Learn More

WIRB-Copernicus Group and the PCCTC Announce New Partnership

Press Releases by WIRB-Copernicus Group September 30, 2015

PRINCETON, N.J. and NEW YORK, Sept. 29, 2015 /PRNewswire/ — WIRB-Copernicus Group® ...

Learn More

Study led by PCCTC site describes prostate cancer’s genomic landscape

Press Releases by Nicole Fawcett, University of of Michigan Comprehensive Cancer Center May 29, 2015

ANN ARBOR, Mich. — An international collaboration of researchers are advancing precision...

Learn More

PCCTC Trial Demonstrates Longer Disease Control with Enzalutamide

Press Releases by PCCTC April 2, 2015

SAN FRANCISCO, CA and TOKYO, JAPAN — (Marketwired) — 04/02/15 — Medivati...

Learn More

Epic Sciences and The PCCTC Collaborate to Advance Therapeutic Development

Press Releases by PCCTC March 9, 2015

SAN DIEGO – March 9, 2015 – Epic Sciences and The Prostate Cancer Clinical Trials Cons...

Learn More

PCCTC Study Shows Zytiga May Improve Outcomes When Taken Before Prostatectomy

Press Releases by PCCTC October 14, 2014

To address the need for better therapies for men with high-risk localized prostate cancer,...

Learn More

Radium Ra 223 dichloride (Xofigo Injection) FDA Approved for Castration-Resistant Prostate Cancer (CRPC)

Press Releases by PCCTC September 13, 2014

On May15, 2013, the U. S. Food and Drug Administration (FDA) approved radium Ra 223 dichlo...

Learn More

RFA: PCCTC Affiliate Clinical Research Sites

Press Releases by PCCTC July 22, 2014

The PCCTC is now accepting applications for its Affiliate Clinical Research Site program. ...

Learn More

PCCTC Trial Shows Tasquinimod Prolongs Survival in Metastatic Prostate Cancer

Press Releases by PCCTC November 22, 2013

Survival data from a phase II PCCTC trial of single agent tasquinimod (NCT00560482) furthe...

Learn More

New Test Differentiates Low- and High-Risk Prostate Cancer

Press Releases by PCCTC May 9, 2013

Genomic Health, Inc. announced the launch of its Oncotype DX® prostate cancer test whic...

Learn More

FDA Approves Abiraterone acetate (Zytiga) For Second Indication

Press Releases by PCCTC December 11, 2012

On December 10, 2012, the U. S. Food and Drug Administration (FDA) approved an expanded i...

Learn More
View More News +

Follow Us

Great work on establishing the importance - but potentially distinct and complementary information - of CTCs and cf… https://t.co/g9JYGb6ZGw
@ThePCCTC ensures all stakeholders share responsibilities in development pathways, trial design, data evaluation, a… https://t.co/eo7z9bNX7p
RT @DoraTrial: 🇳🇱 @Franciscuszorg (PI = P. Hamberg, MD) is now enrolling patients to the #DORATrial (NCT03574571), a study to test Radium-2…

Join our team of dedicated clinical research professionals! The Prostate Cancer Clinical Trials Consortium is currently seeking a Quality Manager and Clinical Data Manager to help fulfill our…

2018-23944 Clinical Data Manager, Prostate Cancer Clinical Trials Consortium (PCCTC) | Memorial Sloan Kettering Cancer Center Careers

careers.mskcc.org

Committed to world-class science!

Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.